[null and void]

It's a lot clearer with the footnotes

↵

1. Ames BN

(2006) Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci USA 103:17589–17594.

OpenUrlAbstract/FREE Full TextGoogle Scholar

• ↵
  1. Hou Y,
  2. Wu G

  (2017) Nutritionally nonessential amino acids: A misnomer in nutritional sciences. Adv Nutr 8:137–139.

  OpenUrlFREE Full TextGoogle Scholar
• ↵
  1. Allen LH,
  2. de Benoist B,
  3. Dary O,
  4. Hurrell RF

  (2006) Guidelines on Food Fortification with Micronutrients (WHO, Geneva).

  Google Scholar
• ↵
  1. Mathias MG, et al.

  (2018) Clinical and vitamin response to a short-term multi-micronutrient intervention in brazilian children and teens: From population data to interindividual responses. Mol Nutr Food Res 62:e1700613.

  OpenUrlGoogle Scholar
• ↵
  1. Drewnowski A,
  2. Fulgoni VL 3rd

  (2014) Nutrient density: Principles and evaluation tools. Am J Clin Nutr 99(Suppl):1223S–1228S.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Blumberg JB,
  2. Frei B,
  3. Fulgoni VL 3rd,
  4. Weaver CM,
  5. Zeisel SH

  (2016) Vitamin and mineral intake is inadequate for most Americans: What should we advise patients about supplements? J Fam Pract 65(Suppl 9):S1–S8.

  OpenUrlGoogle Scholar
• ↵
  1. Fulgoni VL 3rd,
  2. Keast DR,
  3. Bailey RL,
  4. Dwyer J

  (2011) Foods, fortificants, and supplements: Where do Americans get their nutrients? J Nutr 141:1847–1854.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Papanikolaou Y,
  2. Brooks J,
  3. Reider C,
  4. Fulgoni VL 3rd

  (2014) U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: Results of an analysis using observational data from NHANES 2003-2008. Nutr J 13:31.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. McCann JC,
  2. Ames BN

  (2009) Vitamin K, an example of triage theory: Is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr 90:889–907.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. McCann JC,
  2. Ames BN

  (2011) Adaptive dysfunction of selenoproteins from the perspective of the triage theory: Why modest selenium deficiency may increase risk of diseases of aging. FASEB J 25:1793–1814.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Kirkwood TB,
  2. Austad SN

  (2000) Why do we age? Nature 408:233–238.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Patrick RP,
  2. Ames BN

  (2014) Vitamin D hormone regulates serotonin synthesis. Part 1: Relevance for autism. FASEB J 28:2398–2413.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Patrick RP,
  2. Ames BN

  (2015) Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: Relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 29:2207–2222.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Ramagopalan SV, et al.

  (2010) A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res 20:1352–1360.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Ames BN

  (2003) The metabolic tune-up: Metabolic harmony and disease prevention. J Nutr 133(Suppl 1):1544S–1548S.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Ekwaru JP,
  2. Zwicker JD,
  3. Holick MF,
  4. Giovannucci E,
  5. Veugelers PJ

  (2014) The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One 9:e111265.

  OpenUrlGoogle Scholar
• ↵
  1. Grant WB, et al.

  (2016) Do studies reporting ‘U’-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects? Dermatoendocrinol 8:e1187349.

  OpenUrlGoogle Scholar
• ↵
  1. Kojima G,
  2. Iliffe S,
  3. Tanabe M

  (2017) Vitamin D supplementation as a potential cause of U-shaped associations between vitamin D levels and negative health outcomes: A decision tree analysis for risk of frailty. BMC Geriatr 17:236.

  OpenUrlGoogle Scholar
• ↵
  1. Veloudi P,
  2. Jones G,
  3. Sharman JE

  (2017) Effectiveness of vitamin D supplementation for cardiovascular health outcomes. Pulse (Basel) 4:193–207.

  OpenUrlGoogle Scholar
• ↵
  1. Blumberg J, et al.

  (2010) Evidence-based criteria in the nutritional context. Nutr Rev 68:478–484.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Michels AJ,
  2. Frei B

  (2013) Myths, artifacts, and fatal flaws: Identifying limitations and opportunities in vitamin C research. Nutrients 5:5161–5192.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Heaney RP

  (2014) Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 72:48–54.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Smith GD,
  2. Wimalawansa SJ

  (2015) Reconciling the irreconcilable: Micronutrients in clinical nutrition and public health. Vitam Miner 4:e136.

  OpenUrlGoogle Scholar
• ↵
  1. Zeisel SH

  (2015) How nutrigenetics can help prove that nutrient-based interventions reduce disease risk. Sight Life 29:60–63.

  OpenUrlGoogle Scholar
• ↵
  1. Brenner H,
  2. Jansen L,
  3. Saum KU,
  4. Holleczek B,
  5. Schöttker B

  (2017) Vitamin D supplementation trials aimed at reducing mortality have much higher power when focusing on people with low serum 25-hydroxyvitamin D concentrations. J Nutr 147:1325–1333.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Grant WB,
  2. Boucher BJ,
  3. Bhattoa HP,
  4. Lahore H

  (2017) Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 177:266–269.

  OpenUrlGoogle Scholar
• ↵
  1. Wagner CL,
  2. Hollis BW,
  3. Kotsa K,
  4. Fakhoury H,
  5. Karras SN

  (2017) Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications. Rev Endocr Metab Disord 18:307–322.

  OpenUrlGoogle Scholar
• ↵
  1. Scragg R

  (2017) Limitations of vitamin D supplementation trials: Why observational studies will continue to help determine the role of vitamin D in health. J Steroid Biochem Mol Biol 177:6–9.

  OpenUrlGoogle Scholar
• ↵
  1. Guallar E,
  2. Stranges S,
  3. Mulrow C,
  4. Appel LJ,
  5. Miller ER 3rd

  (2013) Enough is enough: Stop wasting money on vitamin and mineral supplements. Ann Intern Med 159:850–851.

  OpenUrlPubMedGoogle Scholar
• ↵
  1. Autier P,
  2. Boniol M,
  3. Pizot C,
  4. Mullie P

  (2014) Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol 2:76–89.

  OpenUrlGoogle Scholar
• ↵
  1. Offit PA

  (2013) Do You Believe in Magic? The Sense and Nonsense of Alternative Medicine (HarperCollins, New York).

  Google Scholar
• ↵
  1. Harris WS, et al.

  (2017) Red blood cell polyunsaturated fatty acids and mortality in the Women’s Health Initiative Memory Study. J Clin Lipidol 11:250–259.e5.

  OpenUrlGoogle Scholar
• ↵
  1. Chen GC,
  2. Yang J,
  3. Eggersdorfer M,
  4. Zhang W,
  5. Qin LQ

  (2016) N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: A meta-analysis. Sci Rep 6:28165.

  OpenUrlGoogle Scholar
• ↵
  1. Lacombe RJS,
  2. Chouinard-Watkins R,
  3. Bazinet RP

  (February 9, 2018) Brain docosahexaenoic acid uptake and metabolism. Mol Aspects Med doi:10.1016/j.mam.2017.12.004.

  OpenUrlCrossRefGoogle Scholar
• ↵
  1. Pawelczyk T, et al.

  (2017) Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study. Schizophr Res 195:168–175.

  OpenUrlGoogle Scholar
• ↵
  1. Farzaneh-Far R, et al.

  (2010) Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 303:250–257.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Kiecolt-Glaser JK, et al.

  (2013) Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain Behav Immun 28:16–24.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Fiala M, et al.

  (2015) ω-3 supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J 29:2681–2689.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Alexander DD,
  2. Miller PE,
  3. Van Elswyk ME,
  4. Kuratko CN,
  5. Bylsma LC

  (2017) A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. Mayo Clin Proc 92:15–29.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. O’Keefe JH,
  2. Jacob D,
  3. Lavie CJ

  (2017) Omega-3 fatty acid therapy: The tide turns for a fish story. Mayo Clin Proc 92:1–3.

  OpenUrlGoogle Scholar
• ↵
  1. Mahabir S, et al.

  (2008) Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis 29:949–956.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. DiNicolantonio J,
  2. O’Keefe J,
  3. Wilson W

  (2018) Subclinical magnesium deficiency: A principle driver of cardiovascular disease and a publice health crisis. Open Heart 5:1–16.

  OpenUrlGoogle Scholar
• ↵
  1. Rosanoff A,
  2. Dai Q,
  3. Shapses SA

  (2016) Essential nutrient interactions: Does low or suboptimal magnesium status interact with vitamin D and/or calcium status? Adv Nutr 7:25–43.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Zeisel S

  (2017) Choline, other methyl-donors and epigenetics. Nutrients 9:E445.

  OpenUrlGoogle Scholar
• ↵
  1. Wallace TC,
  2. Fulgoni VL 3rd

  (2016) Assessment of total choline intakes in the United States. J Am Coll Nutr 35:108–112.

  OpenUrlGoogle Scholar
• ↵
  1. Zeisel SH

  (2006) The fetal origins of memory: The role of dietary choline in optimal brain development. J Pediatr 149(Suppl):S131–S136.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Zeisel SH

  (2012) Diet-gene interactions underlie metabolic individuality and influence brain development: Implications for clinical practice derived from studies on choline metabolism. Ann Nutr Metab 60:19–25.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Zeisel SH

  (2012) Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. Mutat Res 733:34–38.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Bouckenooghe T,
  2. Remacle C,
  3. Reusens B

  (2006) Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care 9:728–733.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Huxtable RJ

  (1992) Physiological actions of taurine. Physiol Rev 72:101–163.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Wójcik OP,
  2. Koenig KL,
  3. Zeleniuch-Jacquotte A,
  4. Costa M,
  5. Chen Y

  (2010) The potential protective effects of taurine on coronary heart disease. Atherosclerosis 208:19–25.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Suzuki T,
  2. Nagao A,
  3. Suzuki T

  (2011) Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs. Wiley Interdiscip Rev RNA 2:376–386.

  OpenUrlGoogle Scholar
• ↵
  1. Takahashi Y,
  2. Hatta H

  (2017) Effects of taurine administration on exercise-induced fatigue and recovery. J Phys Fit Sports Med 6:33–39.

  OpenUrlGoogle Scholar
• ↵
  1. Hansen SH,
  2. Andersen ML,
  3. Cornett C,
  4. Gradinaru R,
  5. Grunnet N

  (2010) A role for taurine in mitochondrial function. J Biomed Sci 17:S23.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Jong CJ,
  2. Azuma J,
  3. Schaffer S

  (2012) Mechanism underlying the antioxidant activity of taurine: Prevention of mitochondrial oxidant production. Amino Acids 42:2223–2232.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Schuller-Levis GB,
  2. Park E

  (2004) Taurine and its chloramine: Modulators of immunity. Neurochem Res 29:117–126.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Dypbukt JM, et al.

  (2005) A sensitive and selective assay for chloramine production by myeloperoxidase. Free Radic Biol Med 39:1468–1477.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Sun Q, et al.

  (2016) Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: Randomized, double-blind, placebo-controlled study. Hypertension 67:541–549.

  OpenUrlGoogle Scholar
• ↵
  1. Yamori Y, et al.

  (2009) Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Adv Exp Med Biol 643:13–25.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Xu YJ,
  2. Arneja AS,
  3. Tappia PS,
  4. Dhalla NS

  (2008) The potential health benefits of taurine in cardiovascular disease. Exp Clin Cardiol 13:57–65.

  OpenUrlPubMedGoogle Scholar
• ↵
  1. Li XW,
  2. Gao HY,
  3. Liu J

  (2017) The role of taurine in improving neural stem cells proliferation and differentiation. Nutr Neurosci 20:409–415.

  OpenUrlGoogle Scholar
• ↵
  1. O’Donnell CP, et al.

  (2016) Adjunctive taurine in first-episode psychosis: A phase 2, double-blind, randomized, placebo-controlled study. J Clin Psychiatry 77:e1610–e1617.

  OpenUrlGoogle Scholar
• ↵
  1. Ito T,
  2. Schaffer SW,
  3. Azuma J

  (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42:1529–1539.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Sarkar P,
  2. Basak P,
  3. Ghosh S,
  4. Kundu M,
  5. Sil PC

  (2017) Prophylactic role of taurine and its derivatives against diabetes mellitus and its related complications. Food Chem Toxicol 110:109–121.

  OpenUrlGoogle Scholar
• ↵
  1. Hansen SH

  (2001) The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17:330–346.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Bianchi L, et al.

  (2012) Taurine transporter gene expression in peripheral mononuclear blood cells of type 2 diabetic patients. Amino Acids 42:2267–2274.

  OpenUrlPubMedGoogle Scholar
• ↵
  1. Napoli Z, et al.

  (2016) Taurine transporter gene expression in mononuclear blood cells of type 1 diabetes patients. J Diabetes Res 2016:7313162.

  OpenUrlGoogle Scholar
• ↵
  1. Clark GJ,
  2. Pandya K,
  3. Lau-Cam CA

  (2017) The effect of metformin and taurine, alone and in combination, on the oxidative stress caused by diabetes in the rat brain. Adv Exp Med Biol 975:353–369.

  OpenUrlGoogle Scholar
• ↵
  1. Patel SN,
  2. Lau-Cam CA

  (2017) The effect of taurine and its immediate homologs on diabetes-induced oxidative stress in the brain and spinal cord of rats. Adv Exp Med Biol 975:337–351.

  OpenUrlGoogle Scholar
• ↵
  1. Arany E

  (2017) Maternal taurine supplementation prevents misprogramming. Diet, Nutrition, and Fetal Programming. Nutrition and Health, eds Rajendram R, Preedy V, Patel V (Humana Press, Cham, Switzerland), pp 309–324.

  Google Scholar
• ↵
  1. Schaffer SW,
  2. Jong CJ,
  3. Ramila KC,
  4. Azuma J

  (2010) Physiological roles of taurine in heart and muscle. J Biomed Sci 17:S2.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Kalaras MD,
  2. Richie JP,
  3. Calcagnotto A,
  4. Beelman RB

  (2017) Mushrooms: A rich source of the antioxidants ergothioneine and glutathione. Food Chem 233:429–433.

  OpenUrlGoogle Scholar
• ↵
  1. Seebeck FP

  (2010) In vitro reconstitution of mycobacterial ergothioneine biosynthesis. J Am Chem Soc 132:6632–6633.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Pfeiffer C,
  2. Bauer T,
  3. Surek B,
  4. Schömig E,
  5. Gründemann D

  (2011) Cyanobacteria produce high levels of ergothioneine. Food Chem 129:1766–1769.

  OpenUrlCrossRefGoogle Scholar
• ↵
  1. Ramirez-Martinez A,
  2. Wesolek N,
  3. Yadan J-C,
  4. Moutet M,
  5. Roudot A-C

  (2016) Intake assessment of L-ergothioneine in some european countires and in the United States. Hum Ecol Risk Assess 22:667–677.

  OpenUrlGoogle Scholar
• ↵
  1. Ey J,
  2. Schömig E,
  3. Taubert D

  (2007) Dietary sources and antioxidant effects of ergothioneine. J Agric Food Chem 55:6466–6474.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Hartman PE

  (1990) Ergothioneine as antioxidant. Methods Enzymol 186:310–318.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Franzoni F, et al.

  (2006) An in vitro study on the free radical scavenging capacity of ergothioneine: Comparison with reduced glutathione, uric acid and trolox. Biomed Pharmacother 60:453–457.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Cheah IK,
  2. Tang RM,
  3. Yew TS,
  4. Lim KH,
  5. Halliwell B

  (2017) Administration of pure ergothioneine to healthy human subjects: Uptake, metabolism, and effects on biomarkers of oxidative damage and inflammation. Antioxid Redox Signal 26:193–206.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Servillo L,
  2. DʼOnofrio N,
  3. Balestrieri ML

  (2017) Ergothioneine antioxidant function: From chemistry to cardiovascular therapeutic potential. J Cardiovasc Pharmacol 69:183–191.

  OpenUrlGoogle Scholar
• ↵
  1. Cheah IK,
  2. Feng L,
  3. Tang RMY,
  4. Lim KHC,
  5. Halliwell B

  (2016) Ergothioneine levels in an elderly population decrease with age and incidence of cognitive decline; a risk factor for neurodegeneration? Biochem Biophys Res Commun 478:162–167.

  OpenUrlGoogle Scholar
• ↵
  1. Halliwell B,
  2. Cheah IK,
  3. Drum CL

  (2016) Ergothioneine, an adaptive antioxidant for the protection of injured tissues? A hypothesis. Biochem Biophys Res Commun 470:245–250.

  OpenUrlGoogle Scholar
• ↵
  1. Taubert D, et al.

  (2006) Association of rheumatoid arthritis with ergothioneine levels in red blood cells: A case control study. J Rheumatol 33:2139–2145.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Paul BD,
  2. Snyder SH

  (2010) The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death Differ 17:1134–1140.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Gründemann D, et al.

  (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 102:5256–5261.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Gründemann D

  (2012) The ergothioneine transporter controls and indicates ergothioneine activity—A review. Prev Med 54:S71–S74.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Mathieson I, et al.

  (2015) Genome-wide patterns of selection in 230 ancient Eurasians. Nature 528:499–503.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Peltekova VD, et al.

  (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36:471–475.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Jung ES,
  2. Park HJ,
  3. Kong KA,
  4. Choi JH,
  5. Cheon JH

  (2017) Association study between OCTN1 functional haplotypes and Crohn’s disease in a Korean population. Korean J Physiol Pharmacol 21:11–17.

  OpenUrlGoogle Scholar
• ↵
  1. Kato Y, et al.

  (2010) Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1. Pharm Res 27:832–840.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Pfeiffer C, et al.

  (2015) Knockout of the ergothioneine transporter ETT in zebrafish results in increased 8-oxoguanine levels. Free Radic Biol Med 83:178–185.

  OpenUrlGoogle Scholar
• ↵
  1. Rucker R,
  2. Chowanadisai W,
  3. Nakano M

  (2009) Potential physiological importance of pyrroloquinoline quinone. Altern Med Rev 14:268–277.

  OpenUrlPubMedGoogle Scholar
• ↵
  1. Klinman JP,
  2. Bonnot F

  (2014) Intrigues and intricacies of the biosynthetic pathways for the enzymatic quinocofactors: PQQ, TTQ, CTQ, TPQ, and LTQ. Chem Rev 114:4343–4365.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Kumazawa T,
  2. Sato K,
  3. Seno H,
  4. Ishii A,
  5. Suzuki O

  (1995) Levels of pyrroloquinoline quinone in various foods. Biochem J 307:331–333.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Choi O, et al.

  (2008) Pyrroloquinoline quinone is a plant growth promotion factor produced by Pseudomonas fluorescens B16. Plant Physiol 146:657–668.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Itoh Y, et al.

  (2016) Effect of the antioxidant supplement pyrroloquinoline quinone disodium salt (BioPQQ™) on cognitive functions. Adv Exp Med Biol 876:319–325.

  OpenUrlGoogle Scholar
• ↵
  1. Harris CB, et al.

  (2013) Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J Nutr Biochem 24:2076–2084.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Akagawa M, et al.

  (2016) Identification of lactate dehydrogenase as a mammalian pyrroloquinoline quinone (PQQ)-binding protein. Sci Rep 6:26723.

  OpenUrlGoogle Scholar
• ↵
  1. Stites T, et al.

  (2006) Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr 136:390–396.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Chowanadisai W, et al.

  (2010) Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J Biol Chem 285:142–152.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Nishimura S

  (1983) Structure, biosynthesis, and function of queuosine in transfer RNA. Prog Nucleic Acid Res Mol Biol 28:49–73.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Fergus C,
  2. Barnes D,
  3. Alqasem MA,
  4. Kelly VP

  (2015) The queuine micronutrient: Charting a course from microbe to man. Nutrients 7:2897–2929.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Farkas WR

  (1980) Effect of diet on the queuosine family of tRNAs of germ-free mice. J Biol Chem 255:6832–6835.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Reyniers JP,
  2. Pleasants JR,
  3. Wostmann BS,
  4. Katze JR,
  5. Farkas WR

  (1981) Administration of exogenous queuine is essential for the biosynthesis of the queuosine-containing transfer RNAs in the mouse. J Biol Chem 256:11591–11594.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Boland C,
  2. Hayes P,
  3. Santa-Maria I,
  4. Nishimura S,
  5. Kelly VP

  (2009) Queuosine formation in eukaryotic tRNA occurs via a mitochondria-localized heteromeric transglycosylase. J Biol Chem 284:18218–18227.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Rakovich T, et al.

  (2011) Queuosine deficiency in eukaryotes compromises tyrosine production through increased tetrahydrobiopterin oxidation. J Biol Chem 286:19354–19363.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Watschinger K, et al.

  (2015) Tetrahydrobiopterin and alkylglycerol monooxygenase substantially alter the murine macrophage lipidome. Proc Natl Acad Sci USA 112:2431–2436.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Alrayes N, et al.

  (2016) The alkylglycerol monooxygenase (AGMO) gene previously involved in autism also causes a novel syndromic form of primary microcephaly in a consanguineous Saudi family. J Neurol Sci 363:240–244.

  OpenUrlGoogle Scholar
• ↵
  1. Frye RE

  (2014) Tetrahydrobiopterin deficiency in autism spectrum disorder. N Am J Med Sci (Boston) 7:93–96.

  OpenUrlGoogle Scholar
• ↵
  1. Burton B, et al.

  (2015) A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria. Mol Genet Metab 114:415–424.

  OpenUrlGoogle Scholar
• ↵
  1. Frye RE

  (2015) Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder. Epilepsy Behav 47:147–157.

  OpenUrlGoogle Scholar
• ↵
  1. Marks T,
  2. Farkas WR

  (1997) Effects of a diet deficient in tyrosine and queuine on germfree mice. Biochem Biophys Res Commun 230:233–237.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Varghese S, et al.

  (2017) In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis. Nucleic Acids Res 45:2029–2039.

  OpenUrlGoogle Scholar
• ↵
  1. Klotz LO,
  2. Kröncke KD,
  3. Sies H

  (2003) Singlet oxygen-induced signaling effects in mammalian cells. Photochem Photobiol Sci 2:88–94.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Institute of Medicine

  (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (National Academy Press, Washington, DC).

  Google Scholar
• ↵
  1. Scott-Boyer MP, et al.

  (2016) A network analysis of cofactor-protein interactions for analyzing associations between human nutrition and diseases. Sci Rep 6:19633.

  OpenUrlGoogle Scholar
• ↵
  1. Blumberg JB,
  2. Bailey RL,
  3. Sesso HD,
  4. Ulrich CM

  (2018) The evolving role of multivitamin/multimineral supplement use among adults in the age of personalized nutrition. Nutrients 10:E248.

  OpenUrlGoogle Scholar
• ↵
  1. Lim SS, et al.

  (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2224–2260.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Bao Y, et al.

  (2013) Association of nut consumption with total and cause-specific mortality. N Engl J Med 369:2001–2011.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Micha R, et al.

  (2017) Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA 317:912–924.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Schwingshackl L, et al.

  (2017) Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: A systematic review and meta-analysis of primary prevention trials. Adv Nutr 8:27–39.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Shlisky J, et al.

  (2017) Nutritional considerations for healthy aging and reduction in age-related chronic disease. Adv Nutr 8:17–26.

  OpenUrlAbstractGoogle Scholar
• ↵
  1. Ewald P

  (2002) Plague Time: The New Gem Theory of Disease (Anchor Books, New York).

  Google Scholar
• ↵
  1. Bourke CD,
  2. Berkley JA,
  3. Prendergast AJ

  (2016) Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol 37:386–398.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. García OP,
  2. Long KZ,
  3. Rosado JL

  (2009) Impact of micronutrient deficiencies on obesity. Nutr Rev 67:559–572.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Damms-Machado A,
  2. Weser G,
  3. Bischoff SC

  (2012) Micronutrient deficiency in obese subjects undergoing low calorie diet. Nutr J 11:34.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Via M

  (2012) The malnutrition of obesity: Micronutrient deficiencies that promote diabetes. ISRN Endocrinol 2012:103472.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Amara NB, et al.

  (2014) Multivitamin restriction increases adiposity and disrupts glucose homeostasis in mice. Genes Nutr 9:410.

  OpenUrlGoogle Scholar
• ↵
  1. Agarwal S,
  2. Reider C,
  3. Brooks JR,
  4. Fulgoni VL 3rd

  (2015) Comparison of prevalence of inadequate nutrient intake based on body weight status of adults in the United States: An analysis of NHANES 2001-2008. J Am Coll Nutr 34:126–134.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. McCann JC, et al.

  (2015) A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: Chronic inflammation blunts these improvements. FASEB J 29:3287–3301.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Arnold M,
  2. Renehan AG,
  3. Colditz GA

  (2017) Excess weight as a risk factor common to many cancer sites: Words of caution when interpreting meta-analytic evidence. Cancer Epidemiol Biomarkers Prev 26:663–665.

  OpenUrlFREE Full TextGoogle Scholar
• ↵
  1. Ajala O,
  2. Mold F,
  3. Boughton C,
  4. Cooke D,
  5. Whyte M

  (2017) Childhood predictors of cardiovascular disease in adulthood. A systematic review and meta-analysis. Obes Rev 18:1061–1070.

  OpenUrlPubMedGoogle Scholar
• ↵
  1. Caleyachetty R, et al.

  (2017) Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol 70:1429–1437.

  OpenUrlFREE Full TextGoogle Scholar
• ↵
  1. Lassale C, et al.

  (2017) Separate and combined associations of obesity and metabolic health with coronary heart disease: A pan-European case-cohort analysis. Eur Heart J 39:397–406.

  OpenUrlGoogle Scholar
• ↵
  1. McIntyre RS, et al.

  (2017) Adverse effects of obesity on cognitive functions in individuals at ultra high risk for bipolar disorder: Results from the global mood and brain science initiative. Bipolar Disord 19:128–134.

  OpenUrlGoogle Scholar
• ↵
  1. Rhea EM, et al.

  (2017) Blood-brain barriers in obesity. AAPS J 19:921–930.

  OpenUrlGoogle Scholar
• ↵
  1. Stillman CM,
  2. Weinstein AM,
  3. Marsland AL,
  4. Gianaros PJ,
  5. Erickson KI

  (2017) Body-brain connections: The effects of obesity and behavioral interventions on neurocognitive aging. Front Aging Neurosci 9:115.

  OpenUrlGoogle Scholar
• ↵
  1. Saltiel AR,
  2. Olefsky JM

  (2017) Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest 127:1–4.

  OpenUrlCrossRefPubMedGoogle Scholar
• ↵
  1. Gonzales GB, et al.

  (2015) Flavonoid interactions during digestion, absorption, distribution and metabolism: A sequential structure-activity/property relationship-based approach in the study of bioavailability and bioactivity. Drug Metab Rev 47:175–190.

  OpenUrlGoogle Scholar
• ↵
  1. Ames BN,
  2. Profet M,
  3. Gold LS

  (1990) Dietary pesticides (99.99% all natural). Proc Natl Acad Sci USA 87:7777–7781.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Saul N,
  2. Pietsch K,
  3. Stürzenbaum SR,
  4. Menzel R,
  5. Steinberg CE

  (2013) Hormesis and longevity with tannins: Free of charge or cost-intensive? Chemosphere 93:1005–1008.

  OpenUrlGoogle Scholar
• ↵
  1. Nelson JW,
  2. Breaker RR

  (2017) The lost language of the RNA world. Sci Signal 10:eaam8812.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Ames BN,
  2. Elson-Schwab I,
  3. Silver EA

  (2002) High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): Relevance to genetic disease and polymorphisms. Am J Clin Nutr 75:616–658.

  OpenUrlAbstract/FREE Full TextGoogle Scholar
• ↵
  1. Kaput J,
  2. Rodriguez R

  1. Ames BN,
  2. Suh JH,
  3. Liu J

  (2006) Enzymes lose binding affinity (increase Km) for coenzymes and substrates with age: A strategy for remediation. Nutrigenomics: Discovering the Path to Personalized Nutrition, eds Kaput J, Rodriguez R (John Wiley & Sons, Hoboken, NJ), pp 277–293.

  Google Scholar
• ↵
  1. Liu J,
  2. Atamna H,
  3. Kuratsune H,
  4. Ames BN

  (2002) Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann N Y Acad Sci 959:133–166.

  OpenUrlPubMedGoogle Scholar
• ↵
  1. Höller U, et al.

  (2018) Micronutrient status assessment in humans: Current methods of analysis and future trends. Trends Analyt Chem 102:110–122.

  OpenUrlGoogle Scholar
• ↵
  1. Food Supplements Europe

  (2017) Healthcare cost savings of calcium and vitamin D food supplements in the European Union (Frost & Sullivan, Mountain View, CA).

  Google Scholar
• ↵
  1. Willett WC

  (2013) Nutritional Epidemiology (Oxford Univ Press, New York), 3rd Ed.

  Google Scholar

[logi_cal869]

And clearer what’s missing.

You get the rubber hose for that.